22.02.2018 • NewsADMcornDede Willams

Archer Daniels Midland and Syngenta Settle Lawsuit

Archer Daniels Midland and Syngenta have settled a lawsuit over Syngenta’s...
Archer Daniels Midland and Syngenta have settled a lawsuit over Syngenta’s launch of a biotech corn strain that had negative effects on the US company’s grain exports to China (c) freya-photographer/Shutterstock

US grain merchant Archer Daniels Midland (ADM) and Swiss agrochemicals group Syngenta have settled a lawsuit over Syngenta’s launch of a biotech corn strain that had negative effects on the US company’s grain exports to China.

The settlement was reached in December 2017, according to a filing by ADM with the US stock market watchdog US. Securities and Exchange Commission recently picked up by news agencies.

ADM sued Syngenta in 2013 for selling the corn variety Agrisure Viptera, or MIR 162, in China before the government had approved it for import.  As a result, China rejected US corn cargoes containing the unauthorized strain. This led to losses amounting to “tens of millions of dollars” for ADM, the company has claimed.

The Swiss group was also sued by another major US grain dealer and ADM competitor, Cargill, as well as by US corn growers.  The agrochemicals producer now owned by ChemChina reached a $1.5bn settlement with the growers in September of last year, reports said.  The Cargill case is set be heard in this September of this year.

Syngenta said it “continues to defend itself” against the claims of other exporters. The Swiss producer told Reuters that it “continues to believe that American farmers should have access to the latest US-approved technologies to help them increase their productivity and crop yield.”

The news agency said US growers are also suing ADM, claiming the company was negligent in failing to screen for biotech corn. China’s refusal to accept the shipments caused corn prices to plummet. According to the SEC filing, ADM remains a defendant in court actions in the US state of Illinois, which it has tried unsuccessfully to dismiss.

China approved imports of Viptera corn in 2014.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.